Vaitkevicius H, Ramsay RE, Swisher CB, Husain AM, et al. Intravenous Ganaxolone for the Treatment of Refractory Status Epilepticus: Results from an Open-Label, Dose-Finding, Phase 2 Trial. Epilepsia 2022 Jun 24. doi: 10.1111/epi.17343.
PMID: 35748707